Total Payments
$5,638
2024 Payments
$422.95
Companies
25
Transactions
209
Medicare Patients
1,626
Medicare Billing
$148,776
Payment Breakdown by Category
Food & Beverage$5,482 (97.2%)
Education$156.05 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,482 | 198 | 97.2% |
| Education | $156.05 | 11 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,674 | 40 | $0 (2023) |
| PFIZER INC. | $576.33 | 46 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $473.82 | 19 | $0 (2021) |
| Myovant Sciences Inc. | $412.52 | 9 | $0 (2022) |
| Astellas Pharma US Inc | $321.78 | 12 | $0 (2024) |
| Allergan, Inc. | $315.71 | 17 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $313.62 | 10 | $0 (2024) |
| Lupin Inc. | $227.67 | 10 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $207.30 | 5 | $0 (2018) |
| TherapeuticsMD, Inc. | $184.52 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.95 | 15 | Astellas Pharma US Inc ($276.82) |
| 2023 | $624.15 | 25 | Sumitomo Pharma America, Inc. ($285.26) |
| 2022 | $1,032 | 29 | Myovant Sciences Inc. ($370.46) |
| 2021 | $617.76 | 22 | AbbVie Inc. ($268.11) |
| 2020 | $320.88 | 9 | AbbVie Inc. ($125.00) |
| 2019 | $941.86 | 29 | AbbVie, Inc. ($470.43) |
| 2018 | $1,062 | 49 | PFIZER INC. ($250.80) |
| 2017 | $615.52 | 31 | PFIZER INC. ($166.42) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Biological | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Biological | ||||||
| 10/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $34.98 | General |
| 09/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.36 | General |
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Biological | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Biological | ||||||
| 07/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 07/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Biological | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Biological | ||||||
| 05/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Biological | ||||||
| 04/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Biological | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Biological | ||||||
| 02/28/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: ETONOGESTREL | ||||||
| 02/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Biological | ||||||
| 01/24/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: HORMONE THERAPY | ||||||
| 12/21/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $28.41 | General |
| 12/08/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: WOMENS HEALTH | ||||||
| 12/07/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: WOMENS HEALTH | ||||||
| 11/02/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: WOMENS HEALTH | ||||||
| 10/24/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: HORMONE THERAPY | ||||||
| 09/14/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: WOMENS HEALTH | ||||||
| 09/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Biological | ||||||
| 08/01/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 314 | 342 | $202,715 | $41,632 |
| 2022 | 8 | 413 | 430 | $173,460 | $32,817 |
| 2021 | 9 | 473 | 509 | $203,500 | $42,076 |
| 2020 | 11 | 426 | 439 | $141,370 | $32,251 |
Total Patients
1,626
Total Services
1,720
Medicare Billing
$148,776
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 63 | 66 | $39,200 | $16,322 | 41.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 105 | 116 | $60,700 | $10,643 | 17.5% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 65 | 70 | $65,530 | $6,754 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 41 | $19,885 | $4,091 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 49 | $17,400 | $3,822 | 22.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 91 | 95 | $66,500 | $9,826 | 14.8% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 89 | 93 | $65,100 | $8,876 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 59 | $13,400 | $4,457 | 33.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 66 | 66 | $9,900 | $3,139 | 31.7% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2022 | 12 | 12 | $10,200 | $2,952 | 28.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 55 | 55 | $5,500 | $2,825 | 51.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 32 | 32 | $1,600 | $688.64 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 18 | $1,260 | $53.37 | 4.2% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 91 | 102 | $71,400 | $11,412 | 16.0% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 93 | 104 | $72,800 | $10,918 | 15.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 74 | $18,500 | $5,861 | 31.7% |
| 93975 | Ultrasound scan of abdominal, pelvic, and/or scrotal arterial inflow and venous outflow | Office | 2021 | 14 | 14 | $11,900 | $3,802 | 32.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 52 | 52 | $5,200 | $2,712 | 52.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 53 | 53 | $8,200 | $2,506 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $3,600 | $1,856 | 51.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 35 | $8,750 | $1,620 | 18.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 63 | 63 | $3,150 | $1,388 | 44.1% |
| 76856 | Ultrasound of pelvis | Office | 2020 | 61 | 64 | $44,800 | $6,470 | 14.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 60 | 63 | $44,100 | $6,456 | 14.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 20 | 20 | $5,500 | $3,934 | 71.5% |
About Mitchell Essig
Mitchell Essig is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316044357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mitchell Essig has received a total of $5,638 in payments from pharmaceutical and medical device companies, with $422.95 received in 2024. These payments were reported across 209 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,482).
As a Medicare-enrolled provider, Essig has provided services to 1,626 Medicare beneficiaries, totaling 1,720 services with total Medicare billing of $148,776. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 09/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316044357
Products in Payments
- MYFEMBREE (Drug) $743.55
- LO LOESTRIN FE (Drug) $487.13
- MENOPUR (Drug) $473.82
- Orilissa (Drug) $470.43
- ORILISSA (Drug) $464.30
- Veozah (Drug) $300.32
- PREMARIN (Drug) $294.40
- Lupron (Drug) $249.50
- SOLOSEC (Drug) $227.67
- PVC (Drug) $223.06
- INTRAROSA (Drug) $207.30
- ORIAHNN (Drug) $202.82
- Prolia (Biological) $155.83
- ANNOVERA (Drug) $116.46
- ESTRACE CREAM (Drug) $116.02
- IMVEXXY (Drug) $68.06
- Aptima HSV (Device) $49.26
- NEXTSTELLIS (Drug) $48.42
- Xulane (Drug) $46.14
- Twirla (Drug) $42.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054